The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients.

ABSTRACT:

SUBMITTER: Aldea M 

PROVIDER: S-EPMC7481630 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature